2025 Europe Allergy Diagnostics Market Revenue Opportunities Report
Description
The 2025 Europe Allergy Diagnostics Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Europe allergy diagnostics market include Thermo Fisher Scientific, Siemens Healthineers, Euroimmun Medizinische Labordiagnostika, and Omega Diagnostics Group PLC. Thermo Fisher Scientific, headquartered in the U.S., leads globally with advanced ImmunoCAP™ allergy testing platforms and a strong emphasis on multiplex and precision diagnostics, sustaining a major market share in Europe as well. Siemens Healthineers from Germany focuses on integrating automation and molecular diagnostic technologies to enhance precision allergy testing services in both public and private healthcare sectors. Euroimmun (a PerkinElmer company) and Omega Diagnostics, based in Germany and the UK respectively, have strong European footholds and specialize in providing comprehensive allergy panels and rapid point-of-care testing solutions responsive to the increasing allergy prevalence across Europe.
These companies are leveraging technological innovations and regulatory support (like the EU's IVDR framework) to expand their diagnostic offerings, including component-resolved diagnostics and digital integration for faster, more precise allergy identification. They also invest in strategic partnerships and R&D to improve accessibility and personalized allergy management in a region where over 150 million people are affected by allergic diseases. Omega Diagnostics notably emphasizes home-based allergy testing, targeting the UK's growing demand, while Siemens and Euroimmun are expanding molecular and automation capabilities across Germany and Europe broadly. Growth in these firms aligns with rising allergy awareness and regulatory encouragement for advanced diagnostic assays.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Europe allergy diagnostics market include Thermo Fisher Scientific, Siemens Healthineers, Euroimmun Medizinische Labordiagnostika, and Omega Diagnostics Group PLC. Thermo Fisher Scientific, headquartered in the U.S., leads globally with advanced ImmunoCAP™ allergy testing platforms and a strong emphasis on multiplex and precision diagnostics, sustaining a major market share in Europe as well. Siemens Healthineers from Germany focuses on integrating automation and molecular diagnostic technologies to enhance precision allergy testing services in both public and private healthcare sectors. Euroimmun (a PerkinElmer company) and Omega Diagnostics, based in Germany and the UK respectively, have strong European footholds and specialize in providing comprehensive allergy panels and rapid point-of-care testing solutions responsive to the increasing allergy prevalence across Europe.
These companies are leveraging technological innovations and regulatory support (like the EU's IVDR framework) to expand their diagnostic offerings, including component-resolved diagnostics and digital integration for faster, more precise allergy identification. They also invest in strategic partnerships and R&D to improve accessibility and personalized allergy management in a region where over 150 million people are affected by allergic diseases. Omega Diagnostics notably emphasizes home-based allergy testing, targeting the UK's growing demand, while Siemens and Euroimmun are expanding molecular and automation capabilities across Germany and Europe broadly. Growth in these firms aligns with rising allergy awareness and regulatory encouragement for advanced diagnostic assays.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
